FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+48.4%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$858M
AUM Growth
+$858M
(+47%)
Cap. Flow
+$53.7M
Cap. Flow
% of AUM
6.26%
Top 10 Holdings %
Top 10 Hldgs %
51.45%
Holding
74
New
10
Increased
22
Reduced
15
Closed
14
Top Buys
| 1 |
Y-mAbs Therapeutics
YMAB
|
$26.2M |
| 2 |
Glaukos
GKOS
|
$21.5M |
| 3 |
Genmab
GMAB
|
$20.2M |
| 4 |
Krystal Biotech
KRYS
|
$19.2M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$17.9M |
Top Sells
| 1 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
$30.4M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$15.9M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$12.3M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11M |
| 5 |
AtriCure
ATRC
|
$9.49M |
Sector Composition
| 1 | Healthcare | 78.12% |
| 2 | Communication Services | 3.8% |
| 3 | Energy | 0.29% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
KORU Medical Systems
KRMD
$195M
| $67.6M | 7.88% | 7,532,150 +293,558 | +4% | +$2.64M |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $60.1M | 7.01% | 4,625,202 +575,162 | +14% | +$7.48M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $59.1M | 6.89% | 1,668,740 -348,363 | -17% | -$12.3M |
|
|
SPNE
4
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $53.5M | 6.24% | 5,112,910 +623,357 | +14% | +$6.53M |
|
5
CareDx
CDNA
$727M
| $47.2M | 5.5% | 1,332,938 +247,186 | +23% | +$8.76M |
|
6
Halozyme
HALO
$8.56B
| $39.1M | 4.56% | 1,458,545 -172,046 | -11% | -$4.61M |
|
|
MODN
7
DELISTED
MODEL N, INC.
MODN
| $32.6M | 3.8% | 938,288 +12,367 | +1% | +$430K |
|
8
Insmed
INSM
$28.8B
| $28.2M | 3.29% | 1,024,438 +4,701 | +0.5% | +$129K |
|
9
Tandem Diabetes Care
TNDM
$845M
| $27.7M | 3.23% | 280,350 -5,841 | -2% | -$578K |
|
|
10
Y-mAbs Therapeutics
YMAB
$388M
| $26.2M | 3.06% | +607,621 | New | +$26.2M |
|
11
Teva Pharmaceuticals
TEVA
$21.1B
| $25.7M | 2.99% | 2,084,103 +240,857 | +13% | +$2.97M |
|
|
12
Glaukos
GKOS
$5.5B
| $25M | 2.91% | 651,021 +560,456 | +619% | +$21.5M |
|
|
13
AtriCure
ATRC
$1.84B
| $24.3M | 2.83% | 539,762 -211,056 | -28% | -$9.49M |
|
|
14
Genmab
GMAB
$15.3B
| $20.2M | 2.36% | +596,374 | New | +$20.2M |
|
|
PFNX
15
DELISTED
Pfenex Inc.
PFNX
| $19.6M | 2.29% | 2,348,799 +9,128 | +0.4% | +$76.2K |
|
|
16
Krystal Biotech
KRYS
$4.27B
| $19.2M | 2.24% | +464,179 | New | +$19.2M |
|
17
NeoGenomics
NEO
$1.13B
| $19M | 2.21% | 612,682 +2,018 | +0.3% | +$62.5K |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $18.6M | 2.17% | 294,316 +283,016 | +2,505% | +$17.9M |
|
19
Ultragenyx Pharmaceutical
RARE
$2.89B
| $18.5M | 2.16% | 236,958 -105,645 | -31% | -$8.26M |
|
20
Zymeworks
ZYME
$1.12B
| $17.2M | 2% | 476,690 +331,781 | +229% | +$12M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16.7M | 1.94% | 265,090 +171,761 | +184% | +$10.8M |
|
|
XENT
22
DELISTED
Intersect ENT, Inc
XENT
| $16.1M | 1.87% | 1,187,450 -266,279 | -18% | -$3.61M |
|
23
United Therapeutics
UTHR
$13.8B
| $15.5M | 1.81% | 128,138 -371 | -0.3% | -$44.9K |
|
24
Codexis
CDXS
$246M
| $13.3M | 1.55% | 1,168,022 -318,576 | -21% | -$3.63M |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.7M | 1.48% | 103,310 -1,847 | -2% | -$228K |
|